HighTower Advisors, LLC - ARRAY BIOPHARMA INC ownership

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$690,000
-77.1%
14,866
-88.0%
0.00%
-80.0%
Q1 2019$3,014,000
+128.2%
124,128
+32.6%
0.02%
+100.0%
Q4 2018$1,321,000
-6.4%
93,635
+0.5%
0.01%0.0%
Q3 2018$1,411,000
+251.9%
93,199
+289.2%
0.01%
+233.3%
Q2 2018$401,000
-8.4%
23,945
-11.6%
0.00%
-25.0%
Q1 2018$438,000
+160.7%
27,090
+107.3%
0.00%
+300.0%
Q4 2017$168,000
-50.3%
13,065
-53.0%
0.00%
-66.7%
Q3 2017$338,000
+259.6%
27,787
+136.5%
0.00%
+200.0%
Q4 2016$94,000
-80.9%
11,750
-89.1%
0.00%
-88.9%
Q2 2014$493,000
-4.5%
108,170
-1.5%
0.01%
-10.0%
Q1 2014$516,000
+1.4%
109,790
+8.1%
0.01%0.0%
Q4 2013$509,000101,5520.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders